Morgan Stanley lowered the firm’s price target on Docebo (DCBO) to $28 from $34 and keeps an Equal Weight rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo’s Earnings Call: Balancing Growth and Challenges
- Docebo Inc. Reports Strong Q3 2025 Performance
- Docebo’s Strong Market Position and Growth Potential Earns Buy Rating Despite OEM Concerns
- Docebo’s Q3 2025 Results Highlight Strong Growth and Strategic Wins
- Docebo reports Q3 adjusted EPS 34c, consensus 33c